Cardiff Oncology, Inc.

CRDF - CIK 0001213037

Market cap-

Rank-

SEC filings1,000

CRDF income statement (quarterly)

The table below shows Cardiff Oncology, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Line item	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024
Revenue	$41.00K	$120.00K	$121.00K	$109.00K	$165.00K	$163.00K
Cost of revenue	-	-	-	-	-	-
Gross profit	-	-	-	-	-	-
R&D	-	-	-	-	-	-
SG&A

CRDF annual revenue (10-K history)

Cardiff Oncology, Inc. reported annual revenue of $593.00K for fiscal year 2025. That is down 13.2% from $683.00K in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $381.07K (FY 2016) to $593.00K. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.